Position in KRYS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$19,557,644
+$12,787,079 QoQ
Shares Held
52,621
+100.8% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#56
of 419 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. KRYS ranks #20 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in KRYS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,557,644 | 52,621 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $6,770,565 | 26,210 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $7,138,315 | 28,954 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,686,692 | 26,549 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,423,808 | 10,358 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,811,912 | 37,781 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $69,712 | 445 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $78,272 | 430 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $235,059 | 1,280 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $126,508 | 711 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $3,160,921 | 25,479 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $4,488,968 | 38,698 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,868,681 | 32,953 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,810,313 | 22,612 | Shares | Defined | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||